Abstracts tagged "Glycoproteins and psoriatic arthritis"

Abstract Number: 2080 • 2018 ACR/ARHP Annual Meeting
Plasmatic Glycoprotein and Lipoprotein Nuclear Magnetic Resonance Profiles Associated with Psoriatic Arthritis
Antonio Julià¹, Jose A Pinto-Tasende², Jordi Gratacós³, Rubén Queiro⁴, Carlos Alberto Montilla-Morales⁵, Juan Carlos Torre-Alonso⁶, Jose Javier Perez Venegas⁷, Antonio Fernandez-Nebro⁸, Emília Fernández⁹, Santiago Muñoz-Fernández¹⁰, Carlos M Gonzalez¹¹, Daniel Roig¹², Pedro Zarco¹³, Alba Erra¹⁴, Jesus Rodriguez¹⁵, Santos Castañeda¹⁶, Esteban Rubio-Romero¹⁷, Georgina Salvador¹⁸, Cesar Diaz-Torné¹⁹, Ricardo Blanco²⁰, Alfredo Willisch²¹, José Antonio Mosquera²², Paloma Vela²³, Jesús Tornero²⁴, Simón Sánchez-Fernández²⁵, Hector Corominas²⁶, Julio Ramírez²⁷, María López-Lasanta¹, Raül Tortosa¹, Núria Palau¹, Juan D. Cañete²⁸ and Sara Marsal¹, ¹Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ²Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain, ³Rheumatology Department, Hospital Parc Taulí, Sabadell (Barcelona), Spain, ⁴Rheum-Derm Unit, Hospital Universitario Central de Asturias, Oviedo, Spain, ⁵Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, ⁶Unit Rheumatology, Hospital Monte Naranco, Oviedo, Spain, ⁷Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, ⁸UGC de Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Regional Universitario de Málaga Departamento de Medicina y Dermatología, Universidad de Málaga, MÁLAGA, Spain, ⁹Hospital Universitario Infanta Sofía, Madrid, Spain, ¹⁰Hospital Universitario Infanta Sofia. Madrid. Spain, Mardid, Spain, ¹¹Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ¹²Rheumatology Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat- Barcelona, Spain, ¹³H Fundación Alcorcón, Alcorcón, Spain, ¹⁴Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain, ¹⁵Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, ¹⁶Hospital Universitario La Princesa, IIS-Princesa, Madrid, Spain, ¹⁷Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ¹⁸Rheumatology Unit., Hospital Mutua de Terrassa. Barcelona, Barcelona, Spain, ¹⁹Rheumatology Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, ²⁰Rheumatology Department,, Hospital Marqués de Valdecilla, Santander, Spain, ²¹Complexo Hospitalario de Ourense, Ourense, Spain, ²²Complejo Hospitalario Provincial de Pontevedra, Pontevedra, Spain, ²³Hospital General Universitario de Alicante, Alicante, Spain, ²⁴Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain, ²⁵Rheumatology Department, Hospital General La Mancha Centro, Ciudad Real, Spain, ²⁶Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, ²⁷Rheumatology, Hospital Clínic de Barcelona, Barcelona, Spain, ²⁸Rheumatology Deparment, Hospital Clinic and IDIBAPS, Barcelona, Spain, Barcelona, Spain
Background/Purpose: Psoriatic arthritis (PsA) is an autoimmune disease characterized by the chronic inflammation of the skin and joints. Inflammatory processes translate into changes of the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].